Silencing of oxoglutarate dehydrogenase (OGDH), the enzyme that converts αKG to succinyl-CoA (coenzyme A), increases the αKG:succinate ratio, enhances 5-hmC levels, and reduces tumor growth in p53-null tumors in vivo (Morris et al. 2019). This evidence concerns the gene TP53 and neoplasm.